[RDF data]
Home | Example Publications
PropertyValue
dcterms:bibliographicCitation <http://dblp.uni-trier.de/rec/bibtex/conf/cimcdm/MendozaPAPDA11>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Alberto_Alfonso_Aguilar-Lasserre>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Catherine_Azzaro-Pantel>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Jos%E2%88%9A%C2%A9_L._Perez-Escobedo>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Luc_Pibouleau>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Luis_Fernando_Morales_Mendoza>
dc:creator <https://dblp.l3s.de/d2r/resource/authors/Serge_Domenech>
foaf:homepage <http://dx.doi.org/doi.org%2F10.1109%2FSMDCM.2011.5949271>
foaf:homepage <https://doi.org/10.1109/SMDCM.2011.5949271>
dc:identifier DBLP conf/cimcdm/MendozaPAPDA11 (xsd:string)
dc:identifier DOI doi.org%2F10.1109%2FSMDCM.2011.5949271 (xsd:string)
dcterms:issued 2011 (xsd:gYear)
rdfs:label Selecting the best portfolio alternative from a hybrid multiobjective GA-MCDM approach for New Product Development in the pharmaceutical industry. (xsd:string)
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Alberto_Alfonso_Aguilar-Lasserre>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Catherine_Azzaro-Pantel>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Jos%E2%88%9A%C2%A9_L._Perez-Escobedo>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Luc_Pibouleau>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Luis_Fernando_Morales_Mendoza>
foaf:maker <https://dblp.l3s.de/d2r/resource/authors/Serge_Domenech>
swrc:pages 159-166 (xsd:string)
dcterms:partOf <https://dblp.l3s.de/d2r/resource/publications/conf/cimcdm/2011>
owl:sameAs <http://bibsonomy.org/uri/bibtexkey/conf/cimcdm/MendozaPAPDA11/dblp>
owl:sameAs <http://dblp.rkbexplorer.com/id/conf/cimcdm/MendozaPAPDA11>
rdfs:seeAlso <http://dblp.uni-trier.de/db/conf/cimcdm/cimcdm2011.html#MendozaPAPDA11>
rdfs:seeAlso <https://doi.org/10.1109/SMDCM.2011.5949271>
swrc:series <https://dblp.l3s.de/d2r/resource/conferences/cimcdm>
dc:title Selecting the best portfolio alternative from a hybrid multiobjective GA-MCDM approach for New Product Development in the pharmaceutical industry. (xsd:string)
dc:type <http://purl.org/dc/dcmitype/Text>
rdf:type swrc:InProceedings
rdf:type foaf:Document